162 related articles for article (PubMed ID: 37553047)
21. HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7.
Liao S; Deng D; Hu X; Wang W; Li L; Li W; Zhou J; Xu G; Meng L; Wang S; Ma D
Int J Mol Med; 2013 Jan; 31(1):120-8. PubMed ID: 23128250
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of the relative distribution and gene variation of HPV16 transforming gene at different stages of cervical lesions].
Zhang F; Ding XH; Cai HB; Wang H; Chen CC; Zhang S
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):107-10. PubMed ID: 20403240
[TBL] [Abstract][Full Text] [Related]
23. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
24. Sustained expression of HPV16 E7 oncoprotein promotes p-AKT(Ser473)/p-Src(Tyr527) signaling to drive precancerous lesions to invasive cervical cancer.
Lin Z; Zhao Y; Li Q; Ci X; Ye X; Chen G; Tu Q; Feng W; Jiang P; Zhu S; Xue X; Saunders NA; Zhang L; Zhu X; Zhao KN
Carcinogenesis; 2022 Jun; 43(5):479-493. PubMed ID: 35134836
[TBL] [Abstract][Full Text] [Related]
25. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
Mori S; Ishii Y; Takeuchi T; Kukimoto I
J Virol; 2023 Aug; 97(8):e0081523. PubMed ID: 37578237
[TBL] [Abstract][Full Text] [Related]
26. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
27. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
Castagnino P; Kim HW; Lam LKM; Basu D; White EA
J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state.
Hochmann J; Parietti F; Martínez J; Lopez AC; Carreño M; Quijano C; Boccardo E; Sichero L; Möller MN; Mirazo S; Arbiza J
Mem Inst Oswaldo Cruz; 2020; 115():e190405. PubMed ID: 32187327
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
Smahel M; Nunvar J
Virol J; 2023 Dec; 20(1):287. PubMed ID: 38049810
[TBL] [Abstract][Full Text] [Related]
33. HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.
Paolini F; Curzio G; Cordeiro MN; Massa S; Mariani L; Pimpinelli F; de Freitas AC; Franconi R; Venuti A
Hum Vaccin Immunother; 2017 Feb; 13(2):291-297. PubMed ID: 27929754
[TBL] [Abstract][Full Text] [Related]
34. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
35. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
36. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
37. HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo.
Liao SJ; Deng DR; Zeng D; Zhang L; Hu XJ; Zhang WN; Li L; Jiang XF; Wang CY; Zhou JF; Wang SX; Zhang HW; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):735-742. PubMed ID: 24142729
[TBL] [Abstract][Full Text] [Related]
38. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
[TBL] [Abstract][Full Text] [Related]
39. High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer.
Gao P; Zheng J
Virol J; 2010 Sep; 7():238. PubMed ID: 20846406
[TBL] [Abstract][Full Text] [Related]
40. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
